Universe Pharmaceuticals Inc
UPC3.395USD
-0.085-2.44%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
1.91MMarket Cap
--P/E TTM
Universe Pharmaceuticals Inc
3.395
-0.085-2.44%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2024H2
FY2024H1
FY2023H2
FY2023H1
FY2022H2
FY2022H1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-92.21%-7.08M
-150.63%-2.43M
50.38%-3.68M
-21.57%4.80M
---7.42M
--6.12M
Net income from continuing operations
174.57%4.37M
-1731.28%-13.10M
39.16%-5.87M
-141.31%-715.43K
---9.64M
--1.73M
Operating gains losses
-5.63%236.87K
-3.46%248.86K
3.79%251.00K
-11.75%257.78K
--241.84K
--292.11K
Deferred tax
-193.03%-58.44K
19.44%665.15K
114.21%62.83K
654.62%556.87K
---441.97K
---100.41K
Other non-cash items
-1388.48%-2.61M
1209.33%2.79M
-67.74%202.72K
58.88%-251.89K
--628.31K
---612.53K
Change in working capital
-184.23%-1.40M
-113.21%-653.92K
-7.06%1.67M
3.02%4.95M
--1.79M
--4.81M
-Change in receivables
-76.14%1.64M
-89.70%-3.35M
1264.48%6.87M
42.36%-1.76M
--503.75K
---3.06M
-Change in inventory
332.58%1.62M
105.43%26.55K
-179.25%-695.08K
43.20%-488.75K
--877.10K
---860.52K
-Change in prepaid expenses
-243.05%-1.34M
53.64%-189.36K
455.58%934.56K
-104.12%-408.43K
---262.83K
--9.91M
Cash from non-recurring investing activities
Cash from operating activities
-92.21%-7.08M
-150.63%-2.43M
50.38%-3.68M
-21.57%4.80M
---7.42M
--6.12M
Investing cash flow
Net cash from continuing investing activities
574.63%293.62K
4573.22%30.19K
14.27%43.52K
-98.83%646.00
--38.09K
--55.09K
Capital expenditures
578.77%295.42K
4573.22%30.19K
14.27%43.52K
-98.84%646.00
--38.09K
--55.63K
Net cash flow from disposal of fixed assets
305.14%176.33K
4573.22%30.19K
14.27%43.52K
-98.83%646.00
--38.09K
--55.09K
Net cash flow from intangible asset transactions
--117.29K
----
----
----
----
----
Net cash flow from investment products
----
--0.00
----
----
----
----
Net cash flow from other investing activities
---11.00
---37.47K
----
----
---3.81M
----
Cash from non-current investing activities
Net cash flow from investing activities
-574.65%-293.63K
-10373.07%-67.66K
98.87%-43.52K
98.83%-646.00
---3.85M
---55.09K
Financing cash flow
Cash flow from continuous financing activities
903.29%27.89M
191.59%6.07M
-204.00%-3.47M
10509.27%2.08M
--3.34M
---19.99K
Net cash flow from debt Issuance/repayment
183.15%2.89M
191.59%6.07M
-204.00%-3.47M
10509.27%2.08M
--3.34M
---19.99K
Net cash flow from common stock issuance/repurchase
--25.00M
----
----
----
----
--0.00
Net cash from non-recurrent financing activities
Net cash from financing activities
903.29%27.89M
191.59%6.07M
-204.00%-3.47M
10509.27%2.08M
--3.34M
---19.99K
Net cash flow
Beginning cash balance
-31.59%8.86M
-7.46%5.29M
-9.00%12.95M
-29.30%5.71M
--14.24M
--8.08M
Current period cash flow changes
369.08%20.64M
-50.62%3.58M
10.04%-7.67M
17.61%7.24M
---8.52M
--6.16M
Effect of exchange rate changes
125.45%120.20K
-98.38%5.89K
19.96%-472.25K
215.85%364.08K
---590.00K
--115.27K
Ending cash balance
458.11%29.50M
-31.59%8.86M
-7.46%5.29M
-9.00%12.95M
--5.71M
--14.24M
Free cash flow
-97.90%-7.37M
-151.27%-2.46M
50.05%-3.73M
-20.86%4.80M
---7.46M
--6.06M
Currency unit
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
